iBio (IBIO) Assets (2011 - 2026)
iBio's Assets came in at $99.11 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 327.5% from $23.19 million a year earlier and up 15.5% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Assets (2011 - 2026) Analysis & Trends
Going back to fiscal Q4 2011, iBio's Assets data covers 61 quarters.
- Assets carries a five-year compound annual growth rate of -7.6% (FY2021 to FY2026).
- Going back by fiscal year, Assets was $23.19 million in FY2025 (-19.3%), $28.73 million in FY2024 (-30.3%), $41.21 million in FY2023 (-58.5%) and $99.41 million in FY2022 (-32.4%).
- The fiscal Q4 2026 figure represents the highest quarterly Assets since fiscal Q4 2022.
- Year-over-year, Assets has increased for four consecutive quarters, with growth averaging 110.4% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in fiscal Q3 2026 (growth of 349.3%), and the weakest in fiscal Q3 2025 (a decline of 61.9%).
- Business Quant data shows IBIO's Assets at $85.83 million (Q3 2026), $64.39 million (Q2 2026) and $64.16 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | iBio | 121.75 Mn | 121.75 Mn | - | 99.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.11 Mn |
| Mar 31, 2026 | 85.83 Mn |
| Dec 31, 2025 | 64.39 Mn |
| Sep 30, 2025 | 64.16 Mn |
| Jun 30, 2025 | 23.19 Mn |
| Mar 31, 2025 | 19.10 Mn |
| Dec 31, 2024 | 21.70 Mn |
| Sep 30, 2024 | 24.52 Mn |
| Jun 30, 2024 | 28.73 Mn |
| Mar 31, 2024 | 50.15 Mn |
| Dec 31, 2023 | 34.02 Mn |
| Sep 30, 2023 | 37.68 Mn |
| Jun 30, 2023 | 41.21 Mn |
| Mar 31, 2023 | 44.39 Mn |
| Dec 31, 2022 | 51.80 Mn |
| Sep 30, 2022 | 84.56 Mn |
| Jun 30, 2022 | 99.41 Mn |
| Mar 31, 2022 | 115.37 Mn |
| Dec 31, 2021 | 126.45 Mn |
| Sep 30, 2021 | 143.74 Mn |
API Access
iBio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();